A proposal for lower-than-expected Medicare Advantage rates in 2024 has sent shares of publicly traded health insurers falling.
The... A proposal for lower-than-expected Medicare Advantage rates in 2024 has sent shares of publicly traded health insurers falling. The Centers for Medicare and Medicaid Services on Wednesday proposed new Medicare Advantage rates for 2024, including a core rate increase of 2.09%. Rates have averaged 3.3% over the past five years, according to Oppenheimer analyst Michael Wiederhorn. A final decision is expected April 3.